Codeine is an opioid that can cause tolerance, dependence, opioid use disorder, and overdose. Combination products may add toxicity from paracetamol/acetaminophen or ibuprofen when taken in excess.
AddictionInfo Editorial Team 7 minute read Evidence checked September 4, 2026
Clinical overview
Quick answer
Codeine is an opioid that can cause tolerance, dependence, opioid use disorder, and overdose. Combination products may add toxicity from paracetamol/acetaminophen or ibuprofen when taken in excess.
Evidence checked4 September 2026
Editorial standardReviewed against current clinical and public-health guidance
ScopeEducation only—not diagnosis or individual medical advice
What this means
People metabolise codeine differently, making effects less predictable. Assessment must identify product strength, total tablets, co-ingredients, alcohol, sedatives, pain, and withdrawal.
Key distinctions
Do not exceed label or prescription directions
mixed-product overuse may require urgent toxicology advice even when the person feels well.
Signs and patterns clinicians assess
A clinician looks at the pattern over time, its severity, the person’s baseline, and the consequences—not at one isolated behaviour. Relevant features can include:
taking a medicine in a larger dose, more often, or for longer than directed
using someone else’s medication or using it for intoxication rather than the intended condition
seeking early refills, using several prescribers, concealment, or escalating use
difficulty reducing use because of withdrawal, rebound symptoms, craving, or fear
continued use despite sedation, falls, cognitive problems, mood change, or functional harm
These signs are not a self-diagnosis. Intoxication, withdrawal, prescribed use, pain, sleep disorders, and mental-health conditions can overlap, so assessment should establish what is happening and what is immediately unsafe.
Health and safety risks
Risk depends on the substance or medicine, route, dose, frequency, combinations, physical health, mental health, and environment. Important concerns include:
overdose or profound sedation, especially when depressant medicines are combined
seizure or severe withdrawal from abrupt cessation of some sedatives
falls, driving impairment, memory problems, and accidental injury
misunderstanding physical dependence as moral failure—or mistaking it for addiction without assessment
unmanaged pain, anxiety, insomnia, or ADHD when medication changes are not clinically coordinated
Assessment and treatment
Good care starts with consent, dignity, and a clear assessment of immediate risk. Treatment intensity should be matched to clinical need rather than to marketing labels or a fixed programme length.
a medication reconciliation covering prescriptions, over-the-counter products, alcohol, and other drugs
assessment of therapeutic benefit, harms, dependence, loss of control, and co-occurring conditions
an individual clinician-led taper when a gradual reduction is indicated
treatment of the original pain, sleep, anxiety, or attention problem using safer alternatives where possible
addiction treatment when compulsive use and significant harm meet criteria for a substance use disorder
Recovery plans should state who is responsible for medication, crisis support, physical-health follow-up, family communication, and continuing care. A lapse should trigger prompt reassessment and additional support—not abandonment or shame.
When to seek urgent help
Call emergency services for extreme sleepiness, slowed or stopped breathing, blue/grey lips, seizure, collapse, severe confusion, or suspected overdose. Do not abruptly stop benzodiazepines or other medicines associated with dangerous withdrawal without prescriber guidance.
Questions to ask a treatment provider
Who performs the medical and psychiatric assessment, and what are their current qualifications and registrations?
How is withdrawal, overdose, suicide risk, medication, and physical illness managed?
Which treatments are offered for this specific condition, and what evidence supports them?
What happens if symptoms worsen or hospital care is required?
How are outcomes, complaints, safeguarding, discharge, and continuing care handled?
Codeine is an opioid even when it is sold or prescribed for common symptoms
Codeine is used in some pain medicines and cough products. It can cause sedation, constipation, physical dependence and opioid use disorder. Familiar packaging or a prescription does not remove risk, especially when codeine is combined with paracetamol, ibuprofen or other ingredients that can cause additional harm at high doses.
People metabolise codeine differently, so the opioid effect can be less predictable than the tablet count suggests. Children, breastfeeding infants and people with breathing problems require particular caution under professional guidance.
Signs of dependence and addiction
Physical dependence may appear as withdrawal when a dose is delayed. Addiction involves impaired control, craving and continued use despite harm. A person may begin with legitimate treatment and gradually take codeine for sleep, anxiety or emotional relief rather than the original symptom.
Taking more than directed or running out early
Visiting several pharmacies or prescribers
Using combination products despite stomach, liver or kidney concerns
Feeling unable to work, sleep or cope without codeine
Continuing after falls, sedation or relationship conflict
Buying tablets online or from unregulated sources
Combination-product risks
Many codeine products contain paracetamol or an anti-inflammatory medicine. Taking large numbers can damage the liver, stomach, kidneys or cause bleeding even when the person is focused on the opioid effect. The non-opioid ingredient may create an emergency before opioid symptoms are obvious.
Anyone who has taken more than the recommended amount of a combination product should seek urgent poison or medical advice rather than waiting for symptoms. Liver injury can be serious before the person feels unwell.
Overdose and sedative combinations
Codeine can slow breathing, especially with alcohol, benzodiazepines, sleeping pills, pregabalin, gabapentin or other opioids. Unresponsiveness, slow breathing, unusual snoring and blue or grey lips are emergency signs. Call emergency services and give naloxone if available.
Tablets bought outside a pharmacy may be counterfeit and contain fentanyl. Appearance cannot confirm contents. Naloxone and treatment are relevant when any unregulated opioid pill has been used.
Codeine withdrawal
Withdrawal can include anxiety, sweating, yawning, aches, abdominal cramps, diarrhoea, vomiting and insomnia. It is often intensely uncomfortable and can lead to rapid resumption. Pregnancy, dehydration, physical illness and co-occurring alcohol or benzodiazepine withdrawal need additional medical assessment.
Abrupt stopping is not always the safest approach, particularly after long-term prescribed use. The clinician should distinguish physical dependence from opioid use disorder and select an individual plan.
Assessment
Bring the exact product name, strength and number taken. The clinician needs to know every active ingredient, source, timing, alcohol and other medicines. They assess pain, cough, mental health, withdrawal, overdose, physical health and attempts to change.
Pharmacy records can help identify total exposure, but the conversation should remain non-judgemental. Concealment increases the risk of duplicate products and unsafe prescribing.
Treatment options
When physical dependence is present without addiction, a gradual clinician-led reduction may be appropriate while the original condition is treated in other ways. When opioid use disorder is present, buprenorphine or methadone may provide safer stabilisation and reduce craving. Naltrexone may be suitable for selected patients after an adequate opioid-free interval.
Psychological treatment, peer support and practical controls around pharmacy access can be added. The main medication options are described in medications for opioid use disorder.
Pain and symptom management
The original pain or cough should not be ignored. A clinician can review non-opioid medicines, physical treatment, sleep and underlying diagnosis. Untreated pain can undermine recovery, while ongoing codeine may worsen constipation, sedation and sensitivity to pain in some people.
Do not substitute another opioid without assessment. The total risk includes interactions and the possibility that several products contain the same ingredient.
Choosing a treatment setting
Most codeine problems can be assessed and treated as outpatients when health and housing are stable. Residential care may be considered when several substances, severe mental illness or an unsafe environment make outpatient care difficult. Hospital care is required for overdose or suspected toxicity from combination ingredients.
A private or luxury rehab should provide opioid medication when indicated and coordinate pain care. Verify prescribing, medical cover, naloxone, emergency transfer and aftercare rather than assuming a generic detox is sufficient.
Relapse prevention
Identify access points: pharmacies, online sellers, old prescriptions, family medicine cabinets and healthcare visits. Secure or dispose of unused medicine through approved routes. Plan what happens when pain, insomnia or anxiety returns.
A lapse after abstinence carries overdose risk because tolerance may be lower and counterfeit supply may be involved. Keep naloxone available and contact treatment quickly.
Family support
Family members can encourage an accurate medication review, protect shared supplies and learn overdose response. They should not secretly remove long-term codeine from a dependent person or attempt to control dosing without clinical advice.
Recovery may involve a safe reduction, transition to opioid use disorder medication, improved pain treatment and restored control. Success should include health and function, not only the absence of one tablet.
Regular review is important because risk, pain and medication needs change. A transparent, coordinated plan is safer than repeated short prescriptions and hidden escalation.
Frequently asked questions
Can this condition be treated?
Yes. Treatment should be matched to the substance or behaviour, severity, withdrawal and overdose risk, physical and mental health, previous response, goals, and available support. More than one episode of care may be needed.
Does withdrawal mean someone has an addiction?
Not necessarily. Withdrawal can indicate physical dependence, including during appropriate prescribed treatment. Addiction additionally involves impaired control, prioritisation, and continued use despite harm. A clinician can distinguish these patterns.
What is the safest first step?
Arrange a confidential assessment with a qualified addiction or medical service. Use emergency services immediately for overdose, seizure, breathing difficulty, severe confusion, dangerous psychosis, or immediate suicide risk.
Sources and clinical guidance
Sources are selected for clinical authority and public accessibility. Publication does not imply endorsement of any treatment provider.
Yes. Treatment should be matched to the substance or behaviour, severity, withdrawal and overdose risk, physical and mental health, previous response, goals, and available support.
Does withdrawal always mean someone has an addiction?
No. Withdrawal can indicate physical dependence, including during appropriate prescribed treatment. Addiction additionally involves impaired control, prioritisation, and continued use despite harm.
What is the safest first step?
Arrange a confidential assessment with a qualified addiction or medical service. Use emergency services immediately for overdose, seizure, breathing difficulty, severe confusion, dangerous psychosis, or immediate suicide risk.
Prepared by the AddictionInfo Editorial Team and last evidence-checked on September 4, 2026. We distinguish education from medical advice, link material claims to primary or authoritative sources, and correct substantive errors transparently. Read our editorial standards.
Prescription drug addiction can involve opioids, benzodiazepines, stimulants, sedatives, or other medicines. The key issue is not whether a drug was prescribed,…
Pregabalin and gabapentin are prescribed for selected conditions but can be misused and may cause dependence or withdrawal. Sedation and overdose risk…
Antidepressants can cause discontinuation symptoms when stopped or reduced, but they do not typically produce the intoxication, craving, and compulsive reward-seeking pattern…